World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Amgen's Star Fades Amid Safety Questions
Keywords:
Tags: Pharmaceutical, Healthcare,
Two of Amgen's drugs that treat anemia in cancer and kidney-failure patients have questions raised about their safety and marketing. The two anemia drugs Epogen and Aranesp generate about half of Amgen's sales. THey now have ablack box warning placed on them by FDA requirements.
Safety and marketing issues raised about drugs generating large sales for pharmaceutical companies.
10/25/2006
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Medical Journal Spikes Article On Industry Ties Of Kidney Group - WSJ.com
Wall Street Journal 12/26/2006
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Suit Details How J&J Pushed Sales of Procrit
Wall Street Journal 05/10/2007
BusinessWeek 05/21/2007
Sequel for Vioxx Critic: Attack on Diabetes Pill
Wall Street Journal 05/22/2007
Amgen strategies
04/10/2007
Grouped Articles
Amgen Strikes $10.4 Billion Deal for Onyx
Wall Street Journal 08/26/2013
Amgen Buys Producer of Drugs for Cancer
New York Times 08/25/2013
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Amgen Cuts Mark Biotech Squeeze
Wall Street Journal 08/16/2007
Amgen Selling Japanese Rights to Some Drugs
New York Times 02/05/2008
Amgen Gets a Lift in Deal With Takeda
Wall Street Journal 02/05/2008
Amgen legal settlements
04/10/2007
Grouped Articles
Amgen to Pay $780 Million to Settle Marketing Accusations
New York Times 10/24/2011
Wall Street Journal 04/23/2012
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Amgen partnership with generics manufacturer Watson Pharmaceuticals
10/22/2006
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Amgen and Watson to Work Together on Generic Drugs
New York Times 12/19/2011
Wall Street Journal 04/23/2012
More Low-Cost Generics - WSJ.com
Wall Street Journal 10/22/2006
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Anemia drug marketing practices
04/10/2007
Grouped Articles
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
Amgen Told to Reword Drug Label
New York Times 07/31/2008
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03/12/2008
Stronger Warnings on 3 Drugs for Anemia
New York Times 11/09/2007
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
Slimming down marketing and sales at American and European pharmaceutical companies.
10/25/2006
American and European drug companies are slimming down marketing and sales as the old marketing practices are not working, and new strategies are taking their place.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Wall Street Journal 01/16/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Wall Street Journal 10/21/2008
Glaxo's settlement for aggressive marketing and its overhaul of its marketing effort.
04/10/2007
A $400 million settlement for off-label promotion of Paxil and Wellbutrin antidepressant drugs.
Grouped Articles
GlaxoSmithKline Probes Bribe Allegations in China
Wall Street Journal 06/12/2013
Glaxo Names New China Chief Amid Bribery Probe
Wall Street Journal 07/26/2013
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
Glaxo Braces for Probes, Hires FDA Ex-Litigator
Wall Street Journal 07/23/2008
Glaxo Plans 12% Reduction in Its U.S. Drug Sales Force
Wall Street Journal 11/06/2008
Abbott Labs's $1.6 billion legal settlement for aggressive marketing of neurologic drug Depakote in U.S. nursing homes
04/10/2007
Grouped Articles
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05/08/2012
Abbott to Pay $1.6 Billion Over Illegal Marketing
New York Times 05/07/2012
Wall Street Journal 05/08/2012
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03/12/2008
Stronger Warnings on 3 Drugs for Anemia
New York Times 11/09/2007
Biotech pharmaceutical companies and industry.
03/14/2007
Grouped Articles
Wall Street Journal 07/01/2013
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
Potential for Deals Drives a Big Surge in the Biotech Sector
New York Times 07/11/2013
Biotech Stocks' Rout Perplexes Analysts
Wall Street Journal 04/11/2014
For Booming Biotech Firms, A New Threat: Generics
Wall Street Journal 03/14/2007
BusinessWeek 04/09/2007
Amgen founder biotech scientist Rathmann
04/10/2007
Grouped Articles
George Rathmann, Chief of Amgen, Dies at 84
New York Times 04/23/2012
Wall Street Journal 04/23/2012
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Wall Street Journal 01/13/2011
Amgen management
04/10/2007
Grouped Articles
Amgen and Watson to Work Together on Generic Drugs
New York Times 12/19/2011
Wall Street Journal 04/23/2012
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Amgen performance
04/10/2007
Grouped Articles
Amgen Strikes $10.4 Billion Deal for Onyx
Wall Street Journal 08/26/2013
Amgen Buys Producer of Drugs for Cancer
New York Times 08/25/2013
Amgen and Watson to Work Together on Generic Drugs
New York Times 12/19/2011
Wall Street Journal 04/23/2012
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
J&J and the settlement with the U.S. Justice Department for off-label marketing of drug Risperdal
04/10/2007
Grouped Articles
Johnson & Johnson to Pay $2.2 Billion to Settle U.S. Probes
Wall Street Journal 11/05/2013
J&J Close to Settling Off-Label Probes
Wall Street Journal 06/21/2012
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03/12/2008
Stronger Warnings on 3 Drugs for Anemia
New York Times 11/09/2007
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Large legal settlements in the pharmaceutical industry.
10/25/2006
The settlements also involve drug pricing and marketing.
Grouped Articles
Drug Firms Curb Ties to Doctors
Wall Street Journal 12/18/2013
In Guilty Plea, OxyContin Maker to Pay $600 Million
New York Times 05/10/2007
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07/10/2008
Drug Approval Is Not a Shield From Lawsuits, Justices Rule
New York Times 03/05/2009
FDA and the drug safety, production and marketing practices of pharmaceutical companies.
07/01/2005
The increasing controversy surrounding the safety and marketing of many pharmaceutical products and the role of the FDA in ensuring safe use and avoiding risks to users.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Plan Would Aid Drug Makers in Liability Suits
Wall Street Journal 01/14/2006
FDA Moves Toward Harder Line on Suicide Risks
Wall Street Journal 07/01/2005
Baxter Infusion Pumps Are Target of FDA Probe
Wall Street Journal 07/22/2005
Financial Ties to Industry Cloud Major Depression Study
Wall Street Journal 07/11/2006
Avandia Concerns Reopen a Wider Debate
Wall Street Journal 05/23/2007
Changing marketing landscape for Drug Companies
10/02/2006
Controversial practices of some companies, Changes in the marketing strategies and practices of companies like Pfizer.
Grouped Articles
Glaxo Epilepsy Drug Is Linked to Defects Found in Newborns - WSJ.com
Wall Street Journal 10/02/2006
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Pfizer to Cut 20% Of U.S. Sales Force, Signaling End of Era - WSJ.com
Wall Street Journal 11/29/2006
AstraZeneca Vows to Work With FDA - WSJ.com
Wall Street Journal 11/28/2006
Cephalon Used Improper Tactics To Sell Drug, Probe Finds - WSJ.com
Wall Street Journal 11/21/2006
Taking Risk for Profit, Industry Seeks Cancer Drugs
New York Times 09/02/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us